Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study

Clinical trial NCT07133659 · RECRUITING

Trial details

NCT number: NCT07133659
Sponsor: Al-Mustansiriyah University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

ITP - Immune Thrombocytopenia

Start date: 2025-06-08
Primary completion: 2026-07-08
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.